Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 55

Cited In for PubMed (Select 18820174)

1.

Immune signature of tumor infiltrating immune cells in renal cancer.

Geissler K, Fornara P, Lautenschläger C, Holzhausen HJ, Seliger B, Riemann D.

Oncoimmunology. 2015 Feb 3;4(1):e985082. eCollection 2015 Jan.

PMID:
25949868
2.

Acute psychosocial stress-mediated changes in the expression and methylation of perforin in chronic fatigue syndrome.

Falkenberg VR, Whistler T, Murray JR, Unger ER, Rajeevan MS.

Genet Epigenet. 2013 Jan 28;5:1-9. doi: 10.4137/GEG.S10944. eCollection 2013.

3.

OMIP-024: pan-leukocyte immunophenotypic characterization of PBMC subsets in human samples.

Moncunill G, Han H, Dobaño C, McElrath MJ, De Rosa SC.

Cytometry A. 2014 Dec;85(12):995-8. doi: 10.1002/cyto.a.22580. Epub 2014 Oct 28. No abstract available.

PMID:
25352070
4.

Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Hill BJ, Darrah PA, Ende Z, Ambrozak DR, Quinn KM, Darko S, Gostick E, Wooldridge L, van den Berg HA, Venturi V, Larsen M, Davenport MP, Seder RA, Price DA, Douek DC.

J Immunol. 2014 Dec 1;193(11):5626-36. doi: 10.4049/jimmunol.1401017. Epub 2014 Oct 27.

5.

Coordinated regulation of NK receptor expression in the maturing human immune system.

Strauss-Albee DM, Horowitz A, Parham P, Blish CA.

J Immunol. 2014 Nov 15;193(10):4871-9. doi: 10.4049/jimmunol.1401821. Epub 2014 Oct 6.

PMID:
25288567
6.

A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer.

Taylor GS, Jia H, Harrington K, Lee LW, Turner J, Ladell K, Price DA, Tanday M, Matthews J, Roberts C, Edwards C, McGuigan L, Hartley A, Wilson S, Hui EP, Chan AT, Rickinson AB, Steven NM.

Clin Cancer Res. 2014 Oct 1;20(19):5009-22. doi: 10.1158/1078-0432.CCR-14-1122-T. Epub 2014 Aug 14.

7.

High eomesodermin expression among CD57+ CD8+ T cells identifies a CD8+ T cell subset associated with viral control during chronic human immunodeficiency virus infection.

Simonetta F, Hua S, Lécuroux C, Gérard S, Boufassa F, Sáez-Cirión A, Pancino G, Goujard C, Lambotte O, Venet A, Bourgeois C.

J Virol. 2014 Oct;88(20):11861-71. doi: 10.1128/JVI.02013-14. Epub 2014 Aug 6.

8.

Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.

Naluyima P, Eller MA, Laeyendecker O, Quinn TC, Serwadda D, Sewankambo NK, Gray RH, Michael NL, Wabwire-Mangen F, Robb ML, Sandberg JK.

AIDS. 2014 Jun 1;28(9):1273-8. doi: 10.1097/QAD.0000000000000286.

9.

Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.

Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N.

Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. eCollection 2014. Review.

10.

Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.

Yap M, Boeffard F, Clave E, Pallier A, Danger R, Giral M, Dantal J, Foucher Y, Guillot-Gueguen C, Toubert A, Soulillou JP, Brouard S, Degauque N.

J Am Soc Nephrol. 2014 Aug;25(8):1856-68. doi: 10.1681/ASN.2013080848. Epub 2014 Mar 20.

PMID:
24652799
11.

Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease.

Nielsen CM, White MJ, Goodier MR, Riley EM.

Front Immunol. 2013 Dec 9;4:422. doi: 10.3389/fimmu.2013.00422. Review.

12.

Late steps in secretory lysosome exocytosis in cytotoxic lymphocytes.

van der Sluijs P, Zibouche M, van Kerkhof P.

Front Immunol. 2013 Nov 18;4:359. doi: 10.3389/fimmu.2013.00359. Review.

13.

Activation associated ERK1/2 signaling impairments in CD8+ T cells co-localize with blunted polyclonal and HIV-1 specific effector functions in early untreated HIV-1 infection.

Crawford TQ, Hecht FM, Pilcher CD, Ndhlovu LC, Barbour JD.

PLoS One. 2013 Oct 15;8(10):e77412. doi: 10.1371/journal.pone.0077412. eCollection 2013.

14.

Cytomegalovirus-seropositive children show inhibition of in vitro EBV infection that is associated with CD8+CD57+ T cell enrichment and IFN-γ.

Sohlberg E, Saghafian-Hedengren S, Rasul E, Marchini G, Nilsson C, Klein E, Nagy N, Sverremark-Ekström E.

J Immunol. 2013 Dec 1;191(11):5669-76. doi: 10.4049/jimmunol.1301343. Epub 2013 Oct 18.

15.

Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.

Saghafian-Hedengren S, Sohlberg E, Theorell J, Carvalho-Queiroz C, Nagy N, Persson JO, Nilsson C, Bryceson YT, Sverremark-Ekström E.

J Virol. 2013 Dec;87(24):13446-55. doi: 10.1128/JVI.02382-13. Epub 2013 Oct 2.

16.
17.

Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.

Abrahamsson SV, Angelini DF, Dubinsky AN, Morel E, Oh U, Jones JL, Carassiti D, Reynolds R, Salvetti M, Calabresi PA, Coles AJ, Battistini L, Martin R, Burt RK, Muraro PA.

Brain. 2013 Sep;136(Pt 9):2888-903. doi: 10.1093/brain/awt182. Epub 2013 Jul 17.

18.

Young T Cells Age During a Redirected Anti-Tumor Attack: Chimeric Antigen Receptor-Provided Dual Costimulation is Half the Battle.

Hombach AA, Abken H.

Front Immunol. 2013 Jun 5;4:135. doi: 10.3389/fimmu.2013.00135. eCollection 2013.

19.

Association of human cytomegalovirus DNAaemia and specific granzyme B responses in lung transplant recipients.

Weseslindtner L, Kerschner H, Steinacher D, Kundi M, Jaksch P, Simon B, Hatos-Agyi L, Scheed A, Klepetko W, Puchhammer-Stöckl E.

Clin Exp Immunol. 2013 Sep;173(3):438-43. doi: 10.1111/cei.12123.

20.

Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients.

de Oliveira AL, Amadeu TP, de França Gomes AC, Menezes VM, da Costa Nery JA, Pinheiro RO, Sarno EN.

Immunology. 2013 Sep;140(1):47-60. doi: 10.1111/imm.12108.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk